Yasmin Contraceptive Pill
January 09, 2014
The National Stroke Foundation has advised women to consult their GP if they have any concerns about their contraceptive pill. This comes in the wake of news reports about a possible class action against the manufacturer of a pill known as Yasmin or the related pill, Yaz.
Studies published in the British Medical Journal in 2011 found women using Yasmin or Yaz were three times more likely to develop potentially life-threatening blood clots than those taking other contraceptives. However, the risk of stroke is very low and previous studies of stroke and oral contraceptives suggest one additional stroke per 24,000 women taking the pill for a year. (JAMA paper)
All oral contraceptives carry a small risk of increasing the chance of blood clots
For more information, see the following links:
Studies published in the British Medical Journal in 2011 found women using Yasmin or Yaz were three times more likely to develop potentially life-threatening blood clots than those taking other contraceptives. However, the risk of stroke is very low and previous studies of stroke and oral contraceptives suggest one additional stroke per 24,000 women taking the pill for a year. (JAMA paper)
All oral contraceptives carry a small risk of increasing the chance of blood clots
For more information, see the following links:
- Therapeutic Goods Administration
- Journal of the American Medical Association (JAMA) article
- British Medical Journal (BMJ) article